Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence

D Mipatrini, P Stefanelli, S Severoni… - Pathogens and global …, 2017 - Taylor & Francis
The decline of immunization rates in countries of origin of migrants and refugees, along with
risky conditions during the journey to Europe, may threaten migrants' health. We performed …

[HTML][HTML] Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines

S Esposito, P Stefanelli, NK Fry, G Fedele… - Frontiers in …, 2019 - frontiersin.org
Pertussis is an acute respiratory disease caused by Bordetella pertussis. Due to its
frequency and severity, prevention of pertussis has been considered an important public …

[HTML][HTML] Characteristics of SARS-CoV-2 variants of concern B. 1.1. 7, B. 1.351 or P. 1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

T Funk, A Pharris, G Spiteri, N Bundle… - …, 2021 - eurosurveillance.org
We compared 19,207 cases of SARS-CoV-2 variant B. 1.1. 7/S gene target failure (SGTF),
436 B. 1.351 and 352 P. 1 to non-variant cases reported by seven European countries …

[HTML][HTML] Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020

F Riccardo, M Ajelli, XD Andrianou, A Bella… - …, 2020 - eurosurveillance.org
Background On 20 February 2020, a locally acquired coronavirus disease (COVID-19) case
was detected in Lombardy, Italy. This was the first signal of ongoing transmission of severe …

[HTML][HTML] Omicron variant evolution on vaccines and monoclonal antibodies

M Sabbatucci, A Vitiello, S Clemente, A Zovi… - …, 2023 - Springer
The severe acute respiratory syndrome coronavirus (SARS-CoV)-2 responsible for the
global COVID-19 pandemic has caused almost 760 million confirmed cases and 7 million …

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

U Vogel, MK Taha, JA Vazquez, J Findlow… - The Lancet infectious …, 2013 - thelancet.com
Background A novel multicomponent vaccine against meningococcal capsular group B
(MenB) disease contains four major components: factor-H-binding protein, neisserial …

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination

MJ Bart, SR Harris, A Advani, Y Arakawa, D Bottero… - MBio, 2014 - Am Soc Microbiol
Bordetella pertussis causes pertussis, a respiratory disease that is most severe for infants.
Vaccination was introduced in the 1950s, and in recent years, a resurgence of disease was …

[HTML][HTML] The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014

R Whittaker, JG Dias, M Ramliden, C Ködmön… - Vaccine, 2017 - Elsevier
Background Invasive meningococcal disease (IMD) is a major cause of bacterial meningitis
and septicaemia although infection by some serogroups may be prevented through …

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

S Salmaso, P Mastrantonio, AE Tozzi, P Stefanelli… - …, 2001 - publications.aap.org
Background. In 1992–1993, a randomized, double-blind, placebo-controlled clinical trial of
two 3-component acellular pertussis vaccines was started in 4 of Italy's 20 regions. During …

[HTML][HTML] Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey

SR Harris, MJ Cole, G Spiteri… - The Lancet Infectious …, 2018 - thelancet.com
Background Traditional methods for molecular epidemiology of Neisseria gonorrhoeae are
suboptimal. Whole-genome sequencing (WGS) offers ideal resolution to describe population …